NEW YORK (GenomeWeb News) – Canadian blood-based biomarker development company GeneNews today reported a sharp drop in revenues and a 53 percent rise in its net loss for the first quarter of 2008.
The company reported Q1 revenues of CDN$294,286 ($288,827USD), a drop of 82.4 percent from revenues of CDN$1.7 million in the first quarter of 2007.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.